Powered by: Motilal Oswal
2024-11-12 11:26:00 am | Source: Accord Fintech
Max Healthcare Institute gains on completing acquisition of 100% equity stake of Jaypee Healthcare
Max Healthcare Institute gains on completing acquisition of 100% equity stake of Jaypee Healthcare

Max Healthcare Institute is currently trading at Rs. 1036.05, up by 10.85 points or 1.06% from its previous closing of Rs. 1025.20 on the BSE.

The scrip opened at Rs. 1025.20 and has touched a high and low of Rs. 1064.45 and Rs. 1025.20 respectively. So far 17469 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1117.05 on 24-Sep-2024 and a 52 week low of Rs. 590.25 on 15-Nov-2023.

Last one week high and low of the scrip stood at Rs. 1106.20 and Rs. 1020.95 respectively. The current market cap of the company is Rs. 101806.53 crore.

The promoters holding in the company stood at 23.74%, while Institutions and Non-Institutions held 72.43% and 3.83% respectively.

Max Healthcare Institute has completed the acquisition of 100% equity stake of Jaypee Healthcare (JHL) on November 11, 2024, upon acquisition of remaining 15,53,90,769 equity shares constituting to 36.35% equity stake for an aggregate consideration of around Rs 227 crore. Consequently, JHL has become a wholly-owned subsidiary of the Company.

Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here